Amedisys Board of Directors Authorizes $100 million Stock Repurchase Program
BATON ROUGE, La., Feb. 25, 2019 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), America’s leading independent home health, hospice and personal care company, today announced that its Board of Directors has authorized a stock repurchase program, under …